Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis

Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the only licensed product to prevent RSV infection in at-risk infants and young children is a monoclonal antibod...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Immunol
Главные авторы: Jacque, Emilie, Chottin, Claire, Laubreton, Daphné, Nogre, Michel, Ferret, Cécile, de Marcos, Sandrine, Baptista, Linda, Drajac, Carole, Mondon, Philippe, De Romeuf, Christophe, Rameix-Welti, Marie-Anne, Eléouët, Jean-François, Chtourou, Sami, Riffault, Sabine, Perret, Gérald, Descamps, Delphyne
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2021
Предметы:
Immunology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8215542/
https://ncbi.nlm.nih.gov/pubmed/34163482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.683902
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы